Condition: Ulcerative Colitis (UC) · Ulcerative Colitis · Sponsor: Tanta University
The purpose of this study is to investigate safety and therapeutic efficacy of antihistamine (desloratadine) on inflammation and disease activity when administered as adjuvant therapies with the traditional therapy 5-aminosalisylic acid (mesalamine) in patients with mild to moderate ulcerative colitis.
This description comes directly from the study's public registry record.
Romisaa R Abd Alnapy · +201288667650 · PG_182624@pharm.tanta.edu.eg
Always discuss trial participation with your own doctor first.
| Menofia university Hospitals | Shibīn al Kawm, Menofia, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07333716